Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Malaria news


From To
Lopinavir/ritonavir cuts malaria risk in children with HIV

HIV-infected children in Tororo, Uganda, an area of high malaria transmission, on a lopinavir/ritonavir (LPV/r, or Kaletra)-based antiretroviral (ART) regimen had a significantly lower risk of getting

07 March 2012
Carole Leach-Lemens
'Test and Treat' model offers new strategy for eliminating malaria

Researchers found that actively identifying undiagnosed malaria and then treating those with the disease resulted in significantly lower prevalence of malaria cases compared to a control group.

06 February 2012
Eurekalert Inf Dis
Certain HIV medications reduce risk of malaria in HIV-infected children

A protease inhibitor (PI)-based antiretroviral regimen has been found to reduce the risk of malaria co-infection among young children in Uganda.

05 December 2011
Science Speaks
MALAWI: Painkillers Prescribed for Malaria Amid Drug Shortage

Malawi is experiencing a drug shortage as the country's international donors remain reluctant to release aid meant for the health sector.

16 November 2011
Inter Press Service
Uganda: Research Links Rapid HIV Spread to Malaria Infections

Malaria could be contributing to the spread of HIV in Uganda by making carriers more likely to pass on the viral disease to their sexual partners, according to a new research.

30 September 2011
Gates invests more money in innovative medicine - The Associated Press

Using microwaves to kill malaria parasites and developing a way to give fetuses immunity to HIV are among the dozen ideas the Bill & Melinda Gates Foundation thinks are worth more research dollars, after giving more than 500 scientists seed money to take an initial look at some far-out concepts.

13 July 2011
Associated Press
New study finds rise in global malaria R&D funds leads to largest ever pipeline of new products

A new analysis of progress in the global fight against malaria finds a four-fold increase in annual funding for malaria research and development (R&D) in just 16 years -- increasing from $121 million in 1993 to $612 million in 2009, with a particularly rapid increase since 2004. The funding has generated the strongest pipeline of malaria control and prevention products in history.

28 June 2011
Eurekalert Medicine & Health
HIV drugs can also target tropical parasites, study suggests

Scientists have discovered that drugs used to treat HIV may also one day become lifesaving drugs targeted at parasitic diseases such as leishmaniasis and malaria.

30 May 2011
Science Daily
2020 vision of vaccines for malaria, TB and HIV/AIDS

In a new article, experts discuss recent advances in vaccine development. New tools including systems biology and structure-based antigen design could lead to a deeper understanding of mechanisms of protection and illuminate the path to rational vaccine development to lift the burden of the world's most devastating infectious diseases.

25 May 2011
Science Daily
Leading global health groups call on US to accelerate research

A coalition of 30 leading global health organizations that work on vaccines, drugs, and other tools and technologies that save lives today released a list of recommendations for US policymakers and regulators, calling for acceleration of scientific innovations and streamlining the approval of safe and affordable inventions in order to save more lives around the world.

03 May 2011
Eurekalert HIV

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.